npj Metabolic Health and Disease
Reappraising obesity management in the GLP-1 receptor agonist era
ReviewInterventions
The paper
Imperial College London
npj Metabolic Health and Disease, 20 Aug 2026
Related
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes